文献速递哮喘

澳大利亚难治性及重症哮喘的患病率与疾病负担:一项全国人群调查

Prevalence and burden of difficult-to-treat and severe asthma in Australia: A national population survey.
PubMed 文献 · Respirology · 2024-05-06

该研究基于2021年2—3月澳大利亚全国网络调查,纳入6048名现患哮喘成人,其中1313人(21.7%)符合难治性/重症哮喘(DTTA)标准。DTTA人群症状控制差、现吸烟比例高、多病共存常见,且过去12个月急诊就诊和紧急全科就诊次数显著增加。

要点

  • 约21.7%的现患哮喘成人符合难治性/重症哮喘标准。
  • DTTA人群85.4%有至少一种其他慢性病,焦虑/抑郁最常见。
  • DTTA人群过去12个月紧急全科就诊和急诊就诊风险显著高于非DTTA人群。

核心结论

  • 社区中难治性/重症哮喘患者存在未控制症状、现吸烟、多病共存及高医疗利用负担,可能在登记研究和临床试验中被低估。

研究设计与样本

  • 澳大利亚≥18岁现患哮喘成人的横断面网络调查,按性别、年龄组和州/领地层化,加权样本6048人。

主要发现

  • 1313人(21.7%)满足至少一项DTTA标准;其中50.4%症状控制极差(ACT≤15),36.2%为现吸烟者,85.4%有至少一种其他慢性病,最常见为焦虑/抑郁。
  • DTTA vs 非DTTA:过去12个月至少一次紧急全科就诊为61.4% vs 27.5%(OR 4.8 [4.2-5.5],p<0.0001)。
  • DTTA vs 非DTTA:过去12个月至少一次急诊就诊为41.9% vs 17.9%(OR 3.8 [3.3-4.4],p<0.0001)。

关键数值与推荐

  • DTTA定义为:尽管使用中/高剂量吸入治疗,仍存在症状控制差、急性加重和/或口服糖皮质激素/生物制剂使用。
  • 症状控制极差定义为哮喘控制测试(ACT)≤15。

临床怎么用

  • 在呼吸科门诊应主动识别符合DTTA标准的患者,关注症状控制、吸烟状态及焦虑/抑郁等多病共存,并评估其高急诊就诊风险。

局限性

  • 横断面设计无法推断因果关系;数据来自网络调查面板,可能存在选择偏倚;调查时间为2021年2—3月,结果受当时COVID-19背景影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Most evidence about difficult-to-treat and severe asthma (DTTA) comes from clinical trials and registries. We aimed to identify people with DTTA from a large nationally representative asthma population and describe their characteristics and healthcare utilization compared with people whose asthma was not 'difficult-to-treat'. METHODS: We conducted a cross-sectional survey of Australians aged ≥18 years with current asthma from large web-based survey panels. Enrolment was stratified by gender, age-group and state/territory based on national population data for people with asthma. Difficult-to-treat or severe asthma was defined by poor symptom control, exacerbations and/or oral corticosteroid/biologic use despite medium/high-dose inhaled therapy. Outcomes included exacerbations, healthcare utilization, multimorbidity, quality of life and coronavirus disease of 2019 (COVID-19)-related behaviour. Weighted data were analysed using SAS version 9.4. RESULTS: The survey was conducted in February-March 2021. The weighted sample comprised 6048 adults with current asthma (average age 47.3 ± SD 18.1 years, 59.9% female), with 1313 (21.7%) satisfying ≥1 DTTA criteria. Of these, 50.4% had very poorly controlled symptoms (Asthma Control Test ≤15), 36.2% were current smokers, and 85.4% had ≥1 additional chronic condition, most commonly anxiety/depression. More than twice as many participants with DTTA versus non-DTTA had ≥1 urgent general practitioner (GP) visit (61.4% vs. 27.5%, OR 4.8 [4.2-5.5, p < 0.0001]), or ≥1 emergency room visit (41.9% vs. 17.9%, OR 3.8 [3.3-4.4, p < 0.0001]) in the previous 12 months. CONCLUSION: Our findings emphasize the burden of uncontrolled symptoms, current smoking, multimorbidity and healthcare utilization in people with DTTA in the community, who may be under-represented in registries or clinical trials.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Davis SR, Ampon RD, Poulos LM, et al. Prevalence and burden of difficult-to-treat and severe asthma in Australia: A national population survey. Respirology. 2024. PMID: 38709664. doi:10.1111/resp.14722

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。